FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2109570317> ?p ?o ?g. }

• W2109570317 endingPage "5683" @default.
• W2109570317 startingPage "5679" @default.
• W2109570317 abstract "Cefazolin, a first-generation cephalosporin with activity against methicillin-susceptible Staphylococcus aureus and streptococci, is often used to treat lower limb infections caused by these pathogens. Antimicrobial penetration is often limited in these patients due to compromised vasculature. Therefore, we sought to evaluate the exposure profile of cefazolin in serum and tissue in patients with lower limb infections. An in vivo microdialysis catheter was inserted into the tissue near the margin of the wound and constantly perfused with lactated Ringer's solution. Steady-state serum and tissue samples were simultaneously collected over a dosing interval. Serum protein binding was also assessed. Serum concentrations were analyzed by noncompartmental analysis. Tissue concentrations were corrected for percent in vivo recovery by using the retrodialysis technique. Seven patients with a mean weight of 95.45 ± 18.51 kg and a mean age of 54 ± 19 years were enrolled. Six patients received 1 g every 8 h, and one patient received 2 g every 24 h due to acute kidney injury. The free area under the curve from 0 to 8 h (fAUC0-8) values for serum and wound were 48.0 ± 18.66 and 56.35 ± 41.17 μg · h/ml, respectively, for the patients receiving 1 g every 8 h. The fAUC0-24 values for serum and wound were 1,326.1 and 253.9 μg · h/ml, respectively, for the single patient receiving 2 g every 24 h. The mean tissue penetration ratio (tissue/serum fAUC ratio) was 1.06. These data suggest that the amount of time that free-drug concentrations remain above the MIC (fT>MIC) for cefazolin in wound tissue is adequate to treat patients with lower limb infections." @default.
• W2109570317 created "2016-06-24" @default.
• W2109570317 creator A5029198318 @default.
• W2109570317 creator A5045905093 @default.
• W2109570317 creator A5052243441 @default.
• W2109570317 creator A5083992408 @default.
• W2109570317 creator A5088741251 @default.
• W2109570317 date "2013-11-01" @default.
• W2109570317 modified "2023-09-26" @default.
• W2109570317 title "Tissue Pharmacokinetics of Cefazolin in Patients with Lower Limb Infections" @default.
• W2109570317 cites W1963815742 @default.
• W2109570317 cites W1984072320 @default.
• W2109570317 cites W2063589249 @default.
• W2109570317 cites W2071260810 @default.
• W2109570317 cites W2075680991 @default.
• W2109570317 cites W2079856514 @default.
• W2109570317 cites W2084655721 @default.
• W2109570317 cites W2093390018 @default.
• W2109570317 cites W2094852419 @default.
• W2109570317 cites W2097205258 @default.
• W2109570317 cites W2113717321 @default.
• W2109570317 cites W2118059826 @default.
• W2109570317 cites W2124238405 @default.
• W2109570317 cites W2138016919 @default.
• W2109570317 cites W2164970926 @default.
• W2109570317 cites W2168749478 @default.
• W2109570317 cites W2949705127 @default.
• W2109570317 doi "https://doi.org/10.1128/aac.01348-13" @default.
• W2109570317 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3811311" @default.
• W2109570317 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24041887" @default.
• W2109570317 hasPublicationYear "2013" @default.
• W2109570317 type Work @default.
• W2109570317 sameAs 2109570317 @default.
• W2109570317 citedByCount "23" @default.
• W2109570317 countsByYear W21095703172014 @default.
• W2109570317 countsByYear W21095703172015 @default.
• W2109570317 countsByYear W21095703172016 @default.
• W2109570317 countsByYear W21095703172017 @default.
• W2109570317 countsByYear W21095703172018 @default.
• W2109570317 countsByYear W21095703172019 @default.
• W2109570317 countsByYear W21095703172020 @default.
• W2109570317 countsByYear W21095703172021 @default.
• W2109570317 countsByYear W21095703172022 @default.
• W2109570317 countsByYear W21095703172023 @default.
• W2109570317 crossrefType "journal-article" @default.
• W2109570317 hasAuthorship W2109570317A5029198318 @default.
• W2109570317 hasAuthorship W2109570317A5045905093 @default.
• W2109570317 hasAuthorship W2109570317A5052243441 @default.
• W2109570317 hasAuthorship W2109570317A5083992408 @default.
• W2109570317 hasAuthorship W2109570317A5088741251 @default.
• W2109570317 hasBestOaLocation W21095703171 @default.
• W2109570317 hasConcept C112705442 @default.
• W2109570317 hasConcept C126322002 @default.
• W2109570317 hasConcept C126894567 @default.
• W2109570317 hasConcept C141071460 @default.
• W2109570317 hasConcept C150903083 @default.
• W2109570317 hasConcept C207001950 @default.
• W2109570317 hasConcept C2777288759 @default.
• W2109570317 hasConcept C2777300098 @default.
• W2109570317 hasConcept C2778353156 @default.
• W2109570317 hasConcept C2779489039 @default.
• W2109570317 hasConcept C42219234 @default.
• W2109570317 hasConcept C50156730 @default.
• W2109570317 hasConcept C501593827 @default.
• W2109570317 hasConcept C523546767 @default.
• W2109570317 hasConcept C529278444 @default.
• W2109570317 hasConcept C54355233 @default.
• W2109570317 hasConcept C64778159 @default.
• W2109570317 hasConcept C71924100 @default.
• W2109570317 hasConcept C86803240 @default.
• W2109570317 hasConcept C89423630 @default.
• W2109570317 hasConcept C90924648 @default.
• W2109570317 hasConcept C98274493 @default.
• W2109570317 hasConceptScore W2109570317C112705442 @default.
• W2109570317 hasConceptScore W2109570317C126322002 @default.
• W2109570317 hasConceptScore W2109570317C126894567 @default.
• W2109570317 hasConceptScore W2109570317C141071460 @default.
• W2109570317 hasConceptScore W2109570317C150903083 @default.
• W2109570317 hasConceptScore W2109570317C207001950 @default.
• W2109570317 hasConceptScore W2109570317C2777288759 @default.
• W2109570317 hasConceptScore W2109570317C2777300098 @default.
• W2109570317 hasConceptScore W2109570317C2778353156 @default.
• W2109570317 hasConceptScore W2109570317C2779489039 @default.
• W2109570317 hasConceptScore W2109570317C42219234 @default.
• W2109570317 hasConceptScore W2109570317C50156730 @default.
• W2109570317 hasConceptScore W2109570317C501593827 @default.
• W2109570317 hasConceptScore W2109570317C523546767 @default.
• W2109570317 hasConceptScore W2109570317C529278444 @default.
• W2109570317 hasConceptScore W2109570317C54355233 @default.
• W2109570317 hasConceptScore W2109570317C64778159 @default.
• W2109570317 hasConceptScore W2109570317C71924100 @default.
• W2109570317 hasConceptScore W2109570317C86803240 @default.
• W2109570317 hasConceptScore W2109570317C89423630 @default.
• W2109570317 hasConceptScore W2109570317C90924648 @default.
• W2109570317 hasConceptScore W2109570317C98274493 @default.
• W2109570317 hasIssue "11" @default.
• W2109570317 hasLocation W21095703171 @default.
• W2109570317 hasLocation W21095703172 @default.

• next